Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-02 Sale | 2019-12-04 07:53 am | ACORDA THERAPEUTICS INC | ACOR | Wasman Jane President, Intl and GC | 2,227 | $1.5953 | $3,553 | 117,420 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-22 Option Award | 2024-01-25 06:02 am | N/A 2034-01-22 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 16,000 | $0 | 20,400 (Direct) | View |
| 2023-05-26 Option Award | 2023-07-12 6:45 pm | N/A 2033-05-26 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 55,000 | $0 | 105,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 5:13 pm | N/A 2033-02-02 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 12,000 | $0 | 13,900 (Direct) | View |
| 2023-01-09 Option Award | 2023-01-11 12:30 pm | N/A N/A | ATHERSYS INC | ATHX | Wasman Jane Director | 22,321 | $0 | 35,141 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-20 1:39 pm | N/A 2032-09-16 | ATHERSYS INC | ATHX | Wasman Jane Director | 44,862 | $0 | 82,904 (Direct) | View |
| 2022-05-20 Option Award | 2022-05-23 5:50 pm | N/A 2032-05-20 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 55,000 | $0 | 80,000 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-01 5:07 pm | N/A 2032-01-31 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 9,025 | $0 | 9,025 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-15 5:39 pm | N/A 2031-06-15 | ATHERSYS INC | ATHX | Wasman Jane Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-21 9:03 pm | N/A 2031-05-19 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 4:29 pm | N/A 2031-03-04 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-11-12 Option Award | 2020-11-16 3:44 pm | N/A 2030-11-12 | ATHERSYS INC | ATHX | Wasman Jane Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-15 8:56 pm | N/A 2030-05-15 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-16 9:20 pm | N/A 2030-03-12 | SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2019-11-07 Option Award | 2019-11-12 08:17 am | N/A 2029-11-07 | ACORDA THERAPEUTICS INC | ACOR | Wasman Jane President, Intl and GC | 80,000 | $0 | 80,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-24 5:18 pm | N/A 2029-05-23 | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 13,750 | $0 | 13,750 (Direct) | View |